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biomarkers for primary and secondary OA, respectively, when compared with
healthy individuals.TNF-a is a suitable biomarker for the diagnosis of both primary
and secondary OA when compared to SLE patients, whereas IL-6 and IL-1b were
apparent explicit markers of primary OA, while IL-10 was exclusive for secondary
OA.
Abstract AB1379 – Table 1. lists the values obtained from the ROC curves for the cytokine
panel and NOx for patients clinically diagnosed with primary and secondary osteoarthritis
against normal healthy controls.
Primary OA Secondary OA
AUC
(%)
Cut-off
value*
Sensitivity Specificity AUC
(%)
Cut-off
value*
Sensitivity Specificity
TNF-
a
88.3 >10.8 93.33 80.00 97.0 >28.2 100.00 96.67
IL-10 88.6 >32.67 85.71 92.59 93.1 >32.67 90.00 92.59
IL-6 59.3 >3.98 89.66 40.74 81.2 >12.02 66.67 96.15
IL-1b 85.2 >1.18 96.43 68.42 61.4 >0.88 77.78 57.89
NOx 72.0 >18.89 93.33 60.71 73.0 >18.89 100.00 60.71
*For the cytokines, in pg/ml and for NOx in mmol/l
Conclusions: This preliminary study suggests that higher levels of inflammatory
cytokines are present in secondary OA compared to primary OA. Furthermore,
distinct markers for primary and secondary OA were identified, indivative of the
potential for developing different therapeutic agents for the different types of OA.
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Background: For frequent extra-articular (systemic) manifestations of joints
inflammatory diseases are various damage of the nervous system,2 and the pres-
ence and severity of peripheral neuropathy (PNP) have significance in the clinical
course, which incidence among these patients is 5%–10%.1 Nevertheless, many
clinical and pathogenic aspects of this peripheral neuropathy (PNP) remain
obscure.
Objectives: to evaluate the rate and clinical features of PNP in rheumatoid arthri-
tis (RA), chlamydia urogenital reactive arthritis (ReA), psoriatic arthritis (PA) and
ankylosing spondylitis (AS), to examine the issues of pathogenetic constructions
such changes of the nervous system, define risk factors.
Methods: The study included 416 patients with inflammatory joint diseases,
among them 131 RA patients, 101 ReA, 76 PA and 108 AS. The average age of
the examined was respectively 45, 32, 42 and 38 years, disease duration – 10, 4,
12 and 11 years, male to female ratio – 1:5, 1:1, 1:2 and 10:1.
Results: The frequency of the PNP in RA, ReA, PA and AS was 13%, 19%, 24%
and 34%, while its severity in patients with PA <ReA < RA<AS, and the same type
ratio of motor, sensory and mixed disorders of inflammatory joints diseases, tro-
phic, visceral and vascular vegetative changes, the connexion with the male sex,
the activity of arthritis and the presence of tendovaginitis, participation of immune
disorders, endothelial dysfunction of blood vessels and changes in physical and
chemical rheological viscoelastic properties of blood in the pathogenesis con-
structions of the nervous system lesions are united around. ReA and PA are differ-
ent by frequency of hands and feet distal pathology, the AS – by the beginnings of
tunnel syndrome. RA tends to impact on the PNP digital arteritis, myositis, eye dis-
ease, and Sjogren’s syndrome, ReA – on sacroiliitis, PA – on exudative form of
cutaneous psoriasis, AS – on eye disease, at that, the risk factors for severe
course of neuropathy in RA is considered to involve in the process of elbows, ReA
– intervertebral and facet joints, PA – wrist, AS – sacroiliac. Guillain-Barré syn-
drome develops respectively in 3%, 4%, 5% and 9% of patients with RA, PA, ReA
and AS, or in 24%, 17%, 26% and 27% cases of PNP, which is closely linked to
the presence of tendovaginitis in all inflammatory diseases and severity of articu-
lar syndrome, in RA it depends on the presence of hypothyroidism, in ReA – on
nephropathy and violations of the heart‘s electrical conduction, in AS – on osteo-
porosis, and seropositive for anti-cyclic citrullinated peptide antibody is a risk fac-
tor for such peripheral nervous system disorders.
Conclusions: PNP is a relatively common manifestation of inflammatory dis-
eases of the joints, which correlate with clinical and laboratory signs of the dis-
ease, and in the future such active detection of the nervous system pathology will
be useful for timely follow-up rehabilitation.
REFERENCE:
[1] Oomatia A., Fang H., Petri M., Birnbaum J. Peripheral neuropathies in sys-
temic lupus erythematosus: clinical features, disease associations, and
immunologic characteristics evaluated over a twenty-five-year study period.
Arthritis Rheumatol 2014;66(4):1000–1009.
[2] Sampaio-Barros PD. Epidemiology of spondyloarthritis in Brazil. Am. J.
Med. Sci 2011;341(4): 287–288.
Disclosure of Interest: None declared
DOI: 10.1136/annrheumdis-2018-eular.3736
Education
AB1381 FOUR ANNUAL INTERNATIONAL DIFFERENT
MEETINGS OF RHEUMATOLOGY: COMPARATION OF
THE CONTENTS, ANALYSIS, CHALLENGE AND
OPORTUNITIES
A.J. Pedro1, E. Cuevas1, C. Abud1, R. Moreno1, M. Martinez1, D. Herrera1,
E. Acevedo2, H. Lopez2, D. Ramos2, G. Aguilera Barragan2, G. Martinez2,
T. Luna2, E. Santillan2. 1Rheumatology; 2Hospital Central Ignacio Morones Prieto,
San Luis Potosí, Mexico
Background: The medical meetings are a tool to help us be able to escalate and
actualize the medical knowledge and their quality is a responsibility of Colleges
and Institutions.
Objectives: To assess the academic level of four types of different annual Meet-
ing of Rheumatology
Methods: We used as support information the summaries published in the sup-
plements of the journal Reumatologia Clinica, SE1 Vol. 12 of February 2016, the
supplement SE 1 Vol. 13 of February 2017, the application for electronic media of
the ACR/ARHP 2016 of the American Congress of Rheumatology 2016 and the website for
abstracts of ,EULAR 2017 dedicated to the surveys presented in the XLIV Mexican
Congress of Rheumatology, XLV Mexican Congress of Rheumatology and the
2016 ACR/ARHP Annual Meeting, and EULAR 2017 respectively, of each survey we was
obtained information about of the diverse pathologies, the type of trial, content
and population referred (adults versus children).
Results: 275, 340, 3275 and 4129 were presented in the XLIV Mexican Congress
of Rheumatology, XLV Mexican Congress of Rheumatology, the 2016 ACR/ARHP
Annual Meeting and EULAR 2017 respectively. Rheumatoid arthritis (RA) was the most
common pathology with 23%, 26%, 21% and 27% in CMR 44, CMR 45, ACR 2016
and EULAR 2017 respectively, followed by systemic lupus erythematosus, third
place was vasculitis, beside in international congress was the spondyloartrhitis.
Highlighted, RA the items about of clinic manifestations were accounted for
almost 30% in the Mexican congress and almost 20% in ACR and EULAR.
Observational studies accounted for almost 40% in Mexican congresses vs. 33%
in ACR 2016 and 55% in ,EULAR 2017 beside surveys about of basic research were
minimal in Mexican congress, but in ACR 2016 accounted for 21% and 12% in
.EULAR 2016
The trials about of Paediatric Rheumatology were 12.3%, 5.5% and 4.9% in CMR
44, CMR 45 and ACR 2016 respectively.
Abstract AB1381 – Figure 1. percentage of rheumatic disease
Conclusions: Rheumatology Meeting constitutes a support to obtain the
adequate medical knowledge based in evidence, in this important branch of
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